tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRIS Stock Latest News

Curis Regains Nasdaq Compliance, Remains Under Monitoring Period
Company AnnouncementsCuris Regains Nasdaq Compliance, Remains Under Monitoring Period
3d ago
8K
CRIS
Curis Targets BTKi-Exposed CLL With New Emavusertib Combo Trial: What Investors Should Watch
PremiumCompany Announcements
Curis Targets BTKi-Exposed CLL With New Emavusertib Combo Trial: What Investors Should Watch
28d ago
CRIS
Curis Announces PIPE Financing and Strategic Capital Strengthening
PremiumCompany Announcements
Curis Announces PIPE Financing and Strategic Capital Strengthening
1M ago
8K
CRIS
Curis announces $80.8M private placement
PremiumThe Fly
Curis announces $80.8M private placement
1M ago
CRIS
Curis’s Promising Clinical Developments and Strategic Trials Justify Buy Rating
PremiumRatings
Curis’s Promising Clinical Developments and Strategic Trials Justify Buy Rating
2M ago
CRIS
Curis provides updated data from its frontline AML triplet study
PremiumThe FlyCuris provides updated data from its frontline AML triplet study
2M ago
CRIS
Promising Early Data from Curis’s Emavusertib Study Supports Buy Rating
Premium
Ratings
Promising Early Data from Curis’s Emavusertib Study Supports Buy Rating
2M ago
CRIS
Curis’s Strategic Clinical Advancements and Promising Data Drive Buy Rating
Premium
Ratings
Curis’s Strategic Clinical Advancements and Promising Data Drive Buy Rating
3M ago
CRIS
Curis Inc. Earnings Call: Clinical Progress and Financial Gains
PremiumCompany Announcements
Curis Inc. Earnings Call: Clinical Progress and Financial Gains
3M ago
CRIS
Curis Inc. Advances Cancer Trials with Promising Results
PremiumCompany Announcements
Curis Inc. Advances Cancer Trials with Promising Results
3M ago
CRIS
Curis Completes Sale of Erivedge Business
PremiumCompany Announcements
Curis Completes Sale of Erivedge Business
3M ago
8K
CRIS
Curis reports Q3 EPS (49c), consensus (60c)
PremiumThe Fly
Curis reports Q3 EPS (49c), consensus (60c)
3M ago
CRIS
Curis sees cash and cash equivalents sufficient into 1Q26
PremiumThe FlyCuris sees cash and cash equivalents sufficient into 1Q26
3M ago
CRIS
CRIS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CRIS Earnings this Week: How Will it Perform?
3M ago
CRIS
Curis Inc.’s Promising Study on Emavusertib for AML and MDS: A Potential Game-Changer
Premium
Company Announcements
Curis Inc.’s Promising Study on Emavusertib for AML and MDS: A Potential Game-Changer
4M ago
CRIS
Curis Inc. Advances Lymphoma Treatment with Emavusertib Study
PremiumCompany Announcements
Curis Inc. Advances Lymphoma Treatment with Emavusertib Study
4M ago
CRIS
Curis Granted Nasdaq Compliance Extension Until November
PremiumCompany Announcements
Curis Granted Nasdaq Compliance Extension Until November
4M ago
8K
CRIS
Curis Appeals Nasdaq Delisting Notice After Non-Compliance
PremiumCompany Announcements
Curis Appeals Nasdaq Delisting Notice After Non-Compliance
6M ago
8K
CRIS
Curis files to sell 4.62M shares of common stock for holders
PremiumThe Fly
Curis files to sell 4.62M shares of common stock for holders
6M ago
CRIS
Curis Files Prospectus Supplement for Stock Offering
PremiumCompany AnnouncementsCuris Files Prospectus Supplement for Stock Offering
6M ago
8K
CRIS
Curis Inc. Receives Buy Rating Amid Promising Clinical Developments and Strong Financial Position
Premium
Ratings
Curis Inc. Receives Buy Rating Amid Promising Clinical Developments and Strong Financial Position
6M ago
CRIS
Curis, Inc. Reports Q2 2025 Financial and Clinical Progress
Premium
Company Announcements
Curis, Inc. Reports Q2 2025 Financial and Clinical Progress
6M ago
CRIS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >